Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells.

MLA

Raveendra-Panickar, Dhanya, et al. “Discovery of Novel Furanylbenzamide Inhibitors That Target Oncogenic Tyrosine Phosphatase SHP2 in Leukemia Cells.” Journal of Biological Chemistry, vol. 298, no. 1, Jan. 2022, pp. 1–19. EBSCOhost, https://doi.org/10.1016/j.jbc.2021.101477.

APA

Raveendra-Panickar, D., Finlay, D., Izidro Layng, F., Lambert, L. J., Celeridad, M., Zhao, M., Barbosa, K., De Backer, L. J. S., Kwong, E., Gosalia, P., Rodiles, S., Holleran, J., Ardecky, R., Grotegut, S., Olson, S., Hutchinson, J. H., Pasquale, E. B., Vuori, K., Deshpande, A. J., & Cosford, N. D. P. (2022). Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells. Journal of Biological Chemistry, 298(1), 1–19. https://doi.org/10.1016/j.jbc.2021.101477

Chicago

Raveendra-Panickar, Dhanya, Darren Finlay, Fabiana Izidro Layng, Lester J. Lambert, Maria Celeridad, Ming Zhao, Karina Barbosa, et al. 2022. “Discovery of Novel Furanylbenzamide Inhibitors That Target Oncogenic Tyrosine Phosphatase SHP2 in Leukemia Cells.” Journal of Biological Chemistry 298 (1): 1–19. doi:10.1016/j.jbc.2021.101477.